In recent weeks, much has been made of psychedelic drugs’ potential to redefine mental health treatment.
In 1943, Swiss chemist Albert Hofmann took the first LSD trip – what is it looking like for the compound today?
Results from a systematic review have led to the conclusion that psilocybin is safe to administer in clinical settings, and that there is a need to...
Researchers have said psychedelic-assisted psychotherapy may hold promise for both improving health and saving costs, but that the current therapeutic approach is poorly targeted.
Launching its first European therapy centre in the Netherlands in early 2021, Field Trip Health is providing psychedelic healing experiences using truffles.
In this article, Evan Lewis, director of the Neurology Centre of Toronto, VP Psychedelic Neurology for Numinus and an expert in cannabis and childhood epilepsy, discusses...
A group of experts gathered to discuss microdosing and separate the fact from the fiction regarding the safety and efficacy of the practice.
Heroic Hearts UK CEO Keith Abraham discusses his journey to setting up the organisation which aims to help veterans living with PTSD.
Mindset Pharma says its next-generation psilocybin compounds could change the paradigm of microdosing by limiting the psychedelic effect.
People will now be able to participate in psychedelic-assisted therapy in a group setting as the Institute for Integrative Therapies expands its services to support the...
